Claris Ventures

Claris Ventures is a venture capital firm based in Italy, founded in 2019. It focuses on early-stage investments in high-potential biopharma companies originating from the Italian R&D ecosystem, including local and international ventures. The firm aims to identify and support innovation in the pharmaceutical space, investing in companies developing transformational drugs. Claris Ventures seeks projects that address significant unmet patient needs, aiming for a substantial impact on healthcare by building value around strong scientific foundations. The firm actively engages with research centers, clinical structures, and companies within the Italian life sciences network. This includes teams based in Italy and Italian scientists abroad with strong ties to the country. Claris Ventures offers capital, competence, and hands-on support to facilitate the start of clinical development programs and create value based on clinical evidence. They express a fascination with science and a commitment to aiding innovators addressing critical clinical needs, ranging from rare diseases to oncology, immunology, and other life-threatening conditions. Claris Ventures is authorized by Banca d’Italia and is a member of AIFI (Italian Private Equity and Venture Capital Association). The firm invests through funds like Claris Biotech I and Claris Biotech II. They actively partner with other entities like Exor Ventures and Evotec to enhance their portfolio companies' development and access to resources. Claris Ventures strives to be patient-oriented and science-passionate in their investment approach.

Biopharma, pharmaceuticals, biotechnology, life sciences, oncology, immunology, rare diseases, central nervous system disorders, cardiac regeneration, respiratory diseases, metastasis prevention, ALK positive tumors, immunotherapies

Core thematic spaces, technologies, and target market segments of interest.